Drug Shortage Report for VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP
Report ID | 191332 |
Drug Identification Number | 02394634 |
Brand name | VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP |
Common or Proper name | VANCOMYCIN HCL |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | VANCOMYCIN |
Strength(s) | 1G |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 10LYVI |
ATC code | J01XA |
ATC description | OTHER ANTIBACTERIALS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2023-05-01 |
Estimated end date | 2023-05-19 |
Actual end date | 2023-05-08 |
Shortage status | Resolved |
Updated date | 2023-05-09 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2023-05-09 | English | Compare |
v5 | 2023-05-08 | French | Compare |
v4 | 2023-05-08 | English | Compare |
v3 | 2023-05-03 | English | Compare |
v2 | 2023-05-01 | French | Compare |
v1 | 2023-05-01 | English | Compare |
Showing 1 to 6 of 6